A new cyclolanostane triterpenoid xyloside, soulieoside P (1), and a known oleanane-type saponin, hederasaponin B (2), were isolated from the rhizomes of Souliea vaginata. Their structures were established by extensive spectroscopic and HRESIMS analysis, as well as chemical methods. Compound 1 showed significant inhibitory effects with IC 50 values of 7.6−11.2 μM against three human cancer cell lines, while compound 2 exhibited no hepatoprotective effect on CCl 4 -induced injury of human HepG2 cells, in the tested range of 0.1−100 μM.
Souliea vaginata (Maxim.) Franch. (family Ranunculaceae), a perennial herbaceous plant mainly distributed in western China, is used in traditional medicine for the treatment of conjunctivitis, stomatitis, pharyngitis, and enteritis [1] . Chemical studies on the species showed the presence of cyclolanostane triterpenoid glycosides, alkaloids, and phenolic acids [2−4] . Among these constituents, cyclolanostane-type triterpenoid glycosides are characteristic of the genus Souliea, showing anti-complement, cytotoxic, and hepatoprotective activities [5−7] . Our previous study on the plant disclosed the presence of two new cyclolanostane triterpene glycosides [8] . Further investigation resulted in the isolation of another new cyclolanostane triterpenoid monoxyloside, soulieoside P (1) and a known oleanane-type saponin, hederasaponin B (2), from the ethanolic extract of the rhizomes ( Figure 1 ). Compounds 1 and 2 were tested for their inhibitory activity against three human cancer cell lines and hepatoprotective effect on CCl 4 -induced injury of human HepG2 cells, respectively. (20S)-15β,16β-diacetoxy -18,20-epoxy -3β,25-diol-9,19-cyclolanostan-24-one synthesized using beesioside I as substrate, except that a xylose group was attached at C-3 in 1 [9] . The HMBC experiment ( Figure 2 ) was performed to establish the location of the functional groups and the full structure of 1. The xylose residue was attached at C-3 due to the long-range correlation between the xylopyranosyl anomeric proton at 4.84 (1H, d, J = 7.8 Hz) and C-3 (δ C 88.7). The HMBC spectrum of 1 showed long-range correlations between H-17 and C-16 (δ C 78.3), C-20 (δ C 86.6), H-16 and C-20 (δ C 86.6), the carbonyl group (δ C 171.1), and H-15 and C-30 (δ 15.2), the carbonyl group (δ C 171.4), which confirmed the presence of the OAc-15 and OAc-16 groups. The HMBC experiment also showed the presence of key correlations between H-19 and C-9, C-10; between H-18 and C-12, C-13, C-14, C-17, C-20; between C-24 and H-22, H-23, H-26, H-27. Thus, the configuration at C-20 must be S, and both H-15 and H-16 are ɑ-oriented. The coupling constants between H-16 and H-17 (J = 10.2 Hz) suggested a cis-relationship of the acetoxyl group and the side chain [10] . Consequently, a 16β-acetoxyl configuration was indicated. The coupling constants (J 15,16 = 9.6 Hz) suggested the 15β-acetoxyl configuration. The D-configuration of the xylose unit was confirmed using GC-MS analysis after acidic hydrolysis of 1 following derivatization with L-cysteine methyl ester and silylation [11] . Therefore, the structure of compound 1 was established as (20S)-15β,16β-diacetoxy-18,20-epoxy-3β,25-diol-16-oxo-9 ,19-cyclolanostan-3-O-β-D-xylopyranoside and named soulieoside P, as illustrated in Figure 1 .
The known triterpenoid derivative was identified as hederasaponin B (2) by analysis of its spectroscopic and MS data with those reported in the literature [12] .
Compounds 1 and 2 were tested for their inhibitory activity against three human cancer cell lines and their hepatoprotective effect on CCl 4 -induced injury of human HepG2 cells using MTT assay, respectively. Compound 1 showed significant inhibitory effects with IC 50 values of 7.6−11.2 μM (Table 2) , while compound 2 exhibited no hepatoprotective activity in the tested range of 0.1−100 μM. 
Experimental
General: Optical rotations were obtained on a Perkin-Elmer 341 digital polarimeter (PerkinElmer, Norwalk, CT, USA), IR spectra on a FTIR-8400S spectrometer (Shimadzu, Kyoto, Japan), and NMR spectra, including APT (Attached Proton Test), with a Bruker AV Ⅲ 600 NMR spectrometer (chemical shift values as δ values with TMS as the internal standard) (Bruker, German). HRESIMS spectra were performed on a LTQ-Obitrap XL spectrometer (Thermo Fisher Scientific, Boston, MA, USA). Silica gel (100~200, 200~300 and 400~500 mesh, Qingdao Marine Chemical plant, Qingdao, China) and C 18 reversed-phase silica gel (40-60 μm, Merck, Darmstadt, Germany) were used for column chromatography. Precoated silica gel GF 254 plates (Zhi Fu Huang Wu Pilot Plant of Silica Gel Development, Yantai, China) were used for TLC. All solvents used were of analytical grade (Beijing Chemical Works, Beijing, China). 
Extraction and isolation:
The air-dried and powdered rhizomes of S. vaginata (1.2 kg) were extracted 3 times with 95% ethanol (3 × 3 L) at room temperature. Removal of the ethanol under reduced pressure yielded the extract (165 g), which was suspended in distilled water and the suspension partitioned with ethyl acetate and n-BuOH, successively. The EtOAc-soluble fraction (86 g) was subjected to silica gel (100 ~ 200 mesh) column chromatography using a light petroleum-EtOAc gradient (from 100:0 to 0:100) as eluent, to yield 5 fractions (Fr. A-E). Fr. D (28 g) was applied to a silica gel (200 ~ 300 mesh) column eluting with a dichloromethanemethanol gradient (from 50:1 to 0:1) gradient to afford 5 fractions (Fr. D1-D5). Fr. D3 (4.2 g) was isolated by repeated silica gel CC (400 ~ 500 mesh) eluting with a dichloromethane-methanol gradient (20:1-1:1), followed by preparative TLC eluting with CH 2 Cl 2 -MeOH-formic acid (15:1:0.1-10:1:0.1) to yield 1 (5.8 mg). Fr. D5 (3.8 g) was isolated by repeated silica gel CC (400 ~ 500 mesh) eluting with a dichloromethane-methanol gradient (10:1−1:1) to give 2 (11.6 mg).
Cytotoxic cyclolanostane glycoside from
Acid hydrolysis: Compound 1 (2 mg) was heated in 2 mL of 2M trifluoroacetic acid at 95°C for 2 h. The reaction mixture was extracted 3 times with 2 mL of CHCl 3 . The remaining aqueous layer was concentrated to dryness with EtOH to give a residue, which was dissolved in anhydrous pyridine (2 mL). The sugar was derivatized with L-cysteine methyl ester hydrochloride (3 mg, 60°C, 1 h) and subsequently silylated with hexamethyldisilazane and chlorotrimethylsilane (Fluka) (2:1, 1.5 mL; 60°C, 30 min). Finally, the supernatant (0.5 mL) was analysed by GC-MS (Agilent 7890A/5975C, Agilent Technologies, Santa Clara, CA, USA) under the following conditions: capillary column HP-5 (30 m × 0.25 mm × 0.25 μm); temperature gradient: 150°C for 2 min, then 5°C/min to 210°C; carrier, helium gas (1.0 mL/min); and injection volume: 1.0 μL. The injection and detector temperature were set at 290°C, and the split ratio was 1/10. The presence of D-xylose in the acid hydrolysate of 1 was confirmed by comparison of its retention time with that of a standard sample. The retention times (t R , min) of D-xylose were 8.17 and 9.11 min. Cytotoxic assays: The cytotoxicity of compound 1 was assessed against HT-29, A549, and MDA-MB231 human cancer cell lines by the MTT method. HT-29 cells were grown in RPMI 1640 medium, and MDA-MB231 and A549 cells in DMEM, supplemented with 10%, v/v, FBS and 1% penicillin-streptomycin solution, and were cultured at a density of 2 × 10 4 cells/mL per well in a 96-well microtiter plate (Corning, Suzhou, China) and incubated overnight at 37°C in a humidified atmosphere of 95% air and 5% CO 2 . Then, the cells were treated with test samples for 24 h. After removing the supernatant of each well, a total of 10 µL of MTT solution was added to each well at the time of incubation for 4 h. The formazan crystals in each well were dissolved in lysis buffer overnight at 37°C. The absorbance at 550 nm was measured by an Infinite M200 Pro spectrophotometer (Tecan, Switzerland). The data are expressed as the percentage of the control optical density (OD) values for each experiment.
Soulieoside P
Hepatoprotective activity assay: HepG2 cells were grown in DMEM (Dulbecco's modified Eagle medium) supplemented with 10% FBS (fetal bovine serum), 100 μg/mL penicillin, and 100 μg/mL streptomycin. Cells were incubated at 37°C in a moist atmosphere containing 5% CO 2 . HepG2 cells (5 × 10 4 /well) were plated in a 96-well plate for 16 h. Then, the medium was aspirated and replaced with serum-free medium of different concentrations of compound 2 for 6 h. After removing the supernatant of each well, 10 μL of MTT solution was added to each well at the time of incubation for 4 h. The formazan crystals were solubilized with 100 μL of MTT stop solution and measured using an Infinite M200 Pro spectrophotometer [13] . Cytoprotective activity of test samples on CCl 4 -induced cell injury was investigated. In total, 5 × 10 4 cells were plated per well in 96-well plates with culture medium for 16 h and then exposed to different concentrations of compound 2 for 30 min before exposure to 0.4% CCl 4 for 6 h. Cell viability was determined as described above and the percentage cell viability was expressed as a percentage with the control cells treated with vehicle as 100%. Following treatment, the cells were harvested and resuspended in 0.4% trypan blue solution. The number of blue-stained (dead) and unstained (viable) cells were counted using a hemocytometer.
Supplementary data: Spectral data relating to this article are available online.
